Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ALIMTA ELI LILLY CANADA INC Actual shortage 100MG Updated Report 2024-04-26 226352
APO-MELOXICAM APOTEX INC Actual shortage 1.5G Updated Report 2024-04-26 226348
APO-SITAGLIPTIN MALATE APOTEX INC Actual shortage 100MG Updated Report 2024-04-26 226345
APO-CITALOPRAM APOTEX INC Actual shortage 40MG New Report 2024-04-26 226342
APO-FOSINOPRIL APOTEX INC Actual shortage 10MG New Report 2024-04-26 226339
APO-PRAVASTATIN APOTEX INC Actual shortage 10MG Updated Report 2024-04-26 226336
APO-MIRTAZAPINE APOTEX INC Actual shortage 45MG New Report 2024-04-26 226333
APO-TERAZOSIN APOTEX INC Actual shortage 2MG New Report 2024-04-26 226330
APO-METHYLPHENIDATE APOTEX INC Actual shortage 10MG New Report 2024-04-26 226327
APO-CITALOPRAM APOTEX INC Actual shortage 20MG New Report 2024-04-26 226324

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PANECTYL SEARCHLIGHT PHARMA INC To be discontinued 5MG New Report 2024-04-26 226355
DELATESTRYL BAUSCH HEALTH, CANADA INC. Discontinued 200MG Updated Report 2024-04-26 221772
STRATTERA ELI LILLY CANADA INC Discontinued 18MG Updated Report 2024-04-24 171480
DULOXETINE SANIS HEALTH INC Reversed 30MG Updated Report 2024-04-23 219618
LIDOCAINE HYDROCHLORIDE INJECTION USP HIKMA CANADA LIMITED Discontinued 10MG Updated Report 2024-04-22 225805